Catatonia in DSM 5: Controversies regarding its psychopathology, Clinical presentation and treatment response;Katatónia: Ellentmondások a pszichopatológiával, Klinikai megnyilvánulással és a kezelésre adott válasszal kapcsolatban

Neuropsychopharmacologia Hungarica

Volumn 16, Issue 4, 2014, Pages 189-194

  Ungvari, Gabor S ^a,b  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Catatonia; DSM 5; Psychopathology

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; LORAZEPAM; NEUROLEPTIC AGENT;

CATATONIA; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DSM-5; FOLLOW UP; HUMAN; MOOD DISORDER; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); CONCEPT FORMATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; MENTAL DISEASE; PSYCHOLOGY;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CATATONIA; CLINICAL TRIALS AS TOPIC; CONCEPT FORMATION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; LORAZEPAM; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 84920382052     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. DSM 5. American Psychiatric Publishing, Washington, DC, 2013.
2. Asztalos Z, Egervary L, Andrassy G, Faludi G, Frecska E. Catatonia and neuroleptic malignant syndrome in view of the psychopathological and pathophysiological overlap: a review. (in Hungarian) Neuropsychopharmacol Hung 2014;16:19-28.
3. Berrios GE. The History of Mental Symptoms. Cambridge University Press, Cambridge, England, 1996.
4. Bleuler E. Dementia Praecox or the Group of Schizophrenias. Transl. J Zinkin, International University Press, New York, 1911/1950.
5. Bush G, Fink, M, Petrides G, Dowling F, Francis A. Catatonia I. Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136.
6. Carroll BT, Kirkhart R, Ahuja N, Soovere I, Lauterbach EC, Talbert R. Katatonia: a new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont) 2008; 5:42-50.
7. Chattopadhyay S, Saha I, Dan A, Bhattacharyya K. Clozapine responsive catatonia: a series of five cases. Ind Psychiatry J 2012; 21: 66-68.
8. Clinebell K, Azzam PN, Gopalan P, Haskett R. Guidelines for preventing common medical complications of catatonia: case report and literature review. J Clin Psychiatry 2014; 75:644-651.
9. Docx L, Morrens B, Bervoets C, Hulstijn W, Fransen E, De Hert M, et al. Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr Scand 2012; 126:256-65.
10. Freudenrecih O. McEvoy JP, Goff DC, Fricchione GL. Catatonic coma with profound bradycardia. Psychosomatics, 2007; 48:74-8.
11. Fischel T, Krivoy A, Brenner I, Weizman A. Priapism as an unusual manifestation of catatonia: a case report. Progr. Neuropsychopharmacol Biol Psychiatry 2009; 33:570.
12. Fink M. Catatonia: a syndrome appears, disappears and is rediscovered. Can J Psychiatry, 2009; 54:437-45.
13. Fink M. Catatonia from its creation to DSM-V: considerations for ICD. Ind J Psychiatry, 2011; 53:214.-7.
14. Fink M, Taylor MA. Catatonia. A Clinician’s Guide to Diagnosis and Treatment. Cambridge University Press, Cambridge-New York, 2003.
15. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 2010; 36: 314-320.
16. Francis A, Divadeenam KM, Bush G, Petrides G. Consistency of symptoms in recurrent catatonia. Compr Psychiatry 1997; 38: 56-60.
17. Francis A, Fink M, Appiani F, Bertelsen A, Bolwig TG, Braunig P, et al. Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J ECT 2010; 26: 246-247.
18. Gelenberg AJ. The catatonic syndrome. Lancet, 1976; 1:1339-1341.
19. Gjessing LR. A review of periodic catatonia. Biol Psychiatry 1974; 8: 23-45.
20. Jaspers K. General Psychopathology. Manchester University Press, Manchester UK, 1963.
21. Kahlbaum KL. Die Katatonie oder das Spannungirresein. Hirschwald, Berlin, 1874.
22. Kleinhaus K, Harlap S, Perrin MC, Manor O, Weiser M, Harkavy-Friedman JM, et al. Catatonic schizophrenia: a cohort prospective study. Schizophr Bull 2012; 38: 331-7.
23. Kirkhart R, Ahuja N, Lee JWY, Ramirez J, Talbert R, Faiz K, Ungvari GS, Thomas C, Carroll, BT. The detection and measurement of catatonia. Psychiatry (Edgmont) 2007; 4: 52-56.
24. Kraepelin E. Uber Remissionen bei Katatonie. Allg Z f Psychiat 1896; 52: 1126-1127.
25. Kraepelin E. Dementia Praecox and Paraphrenia. Translated by Barclay RM, Livingstone, Edinburgh, 1913.
26. Kritzinger PR, Jordaan GP. Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol 2001; 4:251-257.
27. Leonhard K. Die Aufteilung der endogenen Psychosen. Akademie Verlag, Berlin, 1957.
28. Lohr JB, Wisniewski AA. Movement Disorders: a Neuropsychiatric Approach. Guildford Press, New York, 1987.
29. McDaniel WW, Spiegel DR, Sahota AK. Topiramate effect in catatonia: a case series. J Neuropsychiatry Clin Neurosci 2006: 18: 234-238.
30. Narayanaswamy JC, Tibrewal P, Zutshi A, Srinivasaraju R, Math BS. Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry 2012; 34: 312-316.
31. Parker GF. DSM 5 and psychotic and mood disorders. J Am Acad Psychiatry Law 2014; 42: 182-190.
32. Peralta V, Cuesta MJ. Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigm revisited. Schizophr Res 1999; 40: 245-253.
33. Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull, 2010; 36:239-242.
34. Salam SA, Kilzieh N. Lorazepam treatment of psychogenic catatonia: an update. J Clin Psychiatry, 1988; 49 (Suppl):16-21.
35. Schanze D, Ekici AB, Pfuhlman B, Reis A, Stober G. Evaluation of conserved and ultra-conserved non-genic sequences in chronic 15q15-linked periodic catatonia. Am J Med Genet B Neuropsychiatr Genet 2012; 159:77-86.
36. Schneider K. Uber Wesen und Bedeutung katatonischer Symptome. Z ges Neurol Psychiatr 1914; 22: 486-505.
37. Seglas T, Chaslin PH. Katatonia. Brain 1890;12:191-222.
38. Sienart P, Rooseler J, Dr Fruyt J. Measuring catatonia: a systematic review of rating scales. J Affect Dis 2011; 135: 1-9.
39. Tandon R, Heckers S, Bustillo J, Barch D, Gaebel, W, Gur RE et al. Catatonia in DSM 5. Schizophr Res 2013; 150: 26-30.
40. Tuerlings JH, van Waarde JA, Verwey B. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment. Gen Hosp Psychiatry 2010; 32:631-635.
41. Ungvari GS, Leung HC, Lee TS. Benzodiazepines and the psychopathology of catatonia. Pharmacopsychiatry 1994; 27: 242-245.
42. Ungvari GS, Chow LY, Leung HCM, Lau BST. Rating chronic catatonia: discrepancy between cross-sectional and longitudinal assessment. Rev Psiq Clin 1999a; 26: 56-61.
43. Ungvari GS, Chiu HFK, Chow LY, Lau BST, Tang WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology 1999b; 142: 393-398.
44. Ungvari GS, Leung SK, N FS, Cheung HKL, Tang WK. Schizophrenia with prominent catatonic features (‘catatonic’ schizophrenia): Demographic and clinical correlates in the chronic phase. Prog. Neuropsychopharmacol Biol Psychiatry 2005; 29: 27-38.
45. Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull 2010; 36: 231-238.
46. Wong E, Ungvari GS, Leung SK, Tang WK. Rating catatonia in patients with chronic schizophrenia: Rasch analysis of the Bush-Francis Catatonia Rating Scale. Int J Methods Psychiatr Res 2007; 16: 161-170.